Education
About Us
Working with TipRanks
Follow Us
Mankind Pharma Ltd. (IN:MANKIND)
:MANKIND
RESEARCH TOOLSreports
Total Valuation
Mankind Pharma Ltd. has a market cap or net worth of ₹1.02T. The enterprise value is ₹971.93B.
Market Cap₹1.02T
Enterprise Value₹971.93B
Share Statistics
Mankind Pharma Ltd. has 412,578,520 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding412,578,520
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Mankind Pharma Ltd.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Mankind Pharma Ltd. is ―. Mankind Pharma Ltd.’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Mankind Pharma Ltd. had revenue of 103.35B and earned 19.13B in profits. Earnings per share was 47.75.
Revenue103.35B
Gross Profit70.66B
Operating Income40.87B
Pretax Income23.99B
Net Income19.13B
EBITDA28.09B
Earnings Per Share (EPS)47.75
Cash Flow
In the last 12 months, operating cash flow was 4.12B and capital expenditures 0.00, giving a free cash flow of 4.12B billion.
Operating Cash Flow4.12B
Free Cash Flow4.12B
Free Cash Flow per Share10.00
Dividends & Yields
Mankind Pharma Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.56
52-Week Price Change6.46%
50-Day Moving Average2.38K
200-Day Moving Average2.48K
Relative Strength Index (RSI)50.02
Average Volume (3m)13.02K
Important Dates
Mankind Pharma Ltd. upcoming earnings date is Jun 3, 2025, TBA Not Confirmed.
Last Earnings DateJan 23, 2025
Next Earnings DateJun 3, 2025
Ex-Dividend Date―
Financial Position
Mankind Pharma Ltd. as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Mankind Pharma Ltd. has paid 4.58B in taxes.
Income Tax4.58B
Effective Tax Rate―
Enterprise Valuation
Mankind Pharma Ltd. EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Mankind Pharma Ltd. has ₹33.86B in cash and marketable securities with ₹8.73B in debt, giving a net cash position of -₹33.86B billion.
Cash & Marketable Securities₹33.86B
Total Debt₹8.73B
Net Cash-₹33.86B
Net Cash Per Share-₹82.08
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Mankind Pharma Ltd. is ₹2,863.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹2,863.75
Price Target Upside23.68% Upside
Analyst ConsensusModerate Buy
Analyst Count4
Revenue Growth Forecast―
EPS Growth Forecast―